The takeaway is clear: expanding indications for weight management therapies will demand tailored endpoints, extended follow-up to confirm durability, and careful management of tolerability as dosing escalates
10.18632/ONCOTARGET.16556 7 AndrzejewskiS.GravelS.-P.PollakM.St-PierreJ
The initial column temperature is 40C, maintained for 5 minutes, then increased at a rate of 35C per minute to 160C, and held for 3 minutes
Pharmacogenomic testing is increasingly used to guide personalized dosing, particularly for agents like capecitabine, where variants in the DPYD gene significantly affect drug metabolism and toxicity risk
[DOI] [PubMed] [Google Scholar] [160].Wakerley BR, Warner R, Cole M, Stone K, Foy C, Sittampalam M (2020)
You can submit a question or connect with the show at strengthchangeseverything.com